Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 10/9/20101 min de lectura
Schmid Laboratories, Inc. et al.; Withdrawal of Approval of Five New Drug Applications
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is withdrawing approval of five new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.
Idioma original de la fuente: Federal Register — Health and Human ServicesAbrir el comunicado original →